The Dental M&A Industry Has a Data Gap Nobody Talks About

Every DSO acquisition deck, PE thesis memo, and dental trade press article hits the same beats. The U.S. DSO market hit $44.7B in 2025 and is growing at 17.9% CAGR toward $196.5B by 2034. Roll-up and acquisition activity accounts for 41.3% of all DSO activity. By 2026, 39% of US dental practices will be DSO-affiliated, up from 23% in 2024. 200 DSO transactions happened in 2024 alone. The silver tsunami of retiring dentists is cresting. PE is aggressive. Consolidation is inevitable.

Everyone knows these numbers. They show up in every market report, every LinkedIn thought piece, every vendor pitch deck.

Now ask a different question. How much time does a DSO biz dev analyst spend per week on manual practice prospecting? What's the typical lead time between a retiring dentist deciding to sell and a broker listing appearing? What share of qualified acquisition targets never reach the buy-side because nobody saw the signal in time?

Nobody publishes those numbers. Not the ADA. Not ADSO. Not the trade press. Not the industry consulting firms. We searched.

The conversation we keep having vs. the conversation we're not

Every market intelligence report treats DSO consolidation as an accomplished fact and moves on to forecasting the next five years. That's the macro conversation. It's useful for capital allocators and M&A leaders who need to size the opportunity.

What it isn't useful for is the biz dev analyst trying to fill next quarter's pipeline. That analyst has a different set of questions:

• Of the 10,000+ dentists in my territory, who's approaching retirement right now?
• Which licenses are expiring in the next 12 months? Which have disciplinary flags? Which Medicare-billing practices are seeing volume drops?
• When a dentist signals they're considering selling (license not renewed on time, Medicare volume drops, address change), how fast does that signal reach a broker's inbox vs. my own?
• How many hours per week is my team spending on the scattered lookups that would get us to answers on any of the above?

None of these have published industry benchmarks. They're the questions that matter most for actual deal sourcing, and they're the ones the industry has collectively decided not to measure.

Why the gap exists

Three reasons.

First, the data is scattered. NPI registry lives with CMS. Licenses live with 50 different state boards, each with their own CSV format (or no CSV at all). Medicare Part B billing lives in annual data releases. NPDB is quarterly and anonymized. Grants.gov is a separate API. No single actor has an incentive to unify these sources for free. The measurement work has always required the kind of patient data engineering that most market-research firms aren't set up to do.

Second, the people who could measure it don't want to. Trade press earns revenue from DSO vendor ads and industry association sponsorships. Neither incentive aligns with publishing "here's how long DSO biz dev teams burn on research before they find a target." That kind of measurement would make vendors look slow and associations look passive. The silence is rational.

Third, brokers benefit from the information asymmetry. Dental practice brokers operate a relationship business where the value is in being the first to know which dentist is thinking about selling. The entire value proposition of a dental broker rests on the lead time between when a seller decides to list and when a buyer finds out. Publishing that lead time figure would, over time, erode the moat.

What we're going to measure

ProviderSignal sits on top of the scattered government data that would make these measurements possible for the first time. Here's what we intend to publish as the next wave of pilot customers onboard.

Measurement 1: Hours per week biz dev teams spend on manual prospecting research. One survey question, delivered to every Growth and Enterprise trial signup: "Before using ProviderSignal, how many hours per week did your team spend on manual research across NPI lookups, state board websites, CMS data, and broker calls?" Bucket responses into 0-10, 10-20, 20-30, 30+. Publish quarterly aggregates after the first 50 responses. The first credible public figure for DSO biz dev time cost.

Measurement 2: Lead time between public signal and broker listing. For a sample of dentists we flag as retirement-age or license-expiring, we'll track the time between the ProviderSignal flag date and the same dentist's practice appearing in any broker listing. The difference is the lead time advantage available to any buyer with access to the underlying data signals. If the average is days, the market is efficient. If the average is months, there's a measurable information asymmetry worth arbitraging. Nobody knows the answer. We'll find out.

Measurement 3: Cohort composition over time. How does the acquisition-ready cohort (retirement-age, solo practice, no DSO affiliation, license in good standing, Medicare-active) shift quarter over quarter as consolidation proceeds? Does it shrink faster in some states than others? Does it concentrate in specific specialties? Today, the answer to those questions lives in nobody's spreadsheet. We can produce it from our existing data within a few hours of each weekly NPI refresh.

Why this matters for your team

If you're reading this as a DSO biz dev leader, you already know the pain of building a weekly pipeline report from scratch every Monday. You also know the pain of hearing about a practice sale from a broker call three weeks after the seller signed an exclusive listing. Both pains are the same underlying problem: information asymmetry between you and the other side of the market.

The M&A conversation in dental has spent the last five years debating whether consolidation will continue. That conversation is over. The answer is yes. The next five years belong to the teams who can answer the operational questions: how fast can you find the target, how early can you reach the seller, how much of your week gets eaten by research that should take 30 seconds.

Those are the measurements we care about. They're the only ones that translate directly into pipeline value. And for the first time, they're measurable.

The call

If your team is doing active acquisition prospecting, we want your time-audit data. We'll publish aggregates anonymously. If you're willing to participate, start a trial and tell us in the onboarding form. Every measurement we publish will include the sample size so you can judge its weight. Everything will be verifiable against raw data by anyone who runs the same queries on NPI and state board files.

We provide the data. You make the sale. And when we all have better measurements of what that actually takes, the whole M&A ecosystem gets more efficient.

Cited industry figures (DSO market size, CAGR, 2024 transaction count, 2026 affiliation rate) come from published trade sources including ADSO, MB2 Dental, and Clerri industry reports. Data-gap observation is based on a search of industry research databases and trade press archives conducted on April 11, 2026. If you find a published benchmark for any of the three measurements above, we'd love to compare notes. Email the team at support@providersignal.com.